Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Therapeutic Drug Monitoring of Sunitinib and Pazopanib in Advanced or Metastatic Renal Cell Carcinoma

NCT02555748 is registered in ClinicalTrials.gov with Institut Claudius Regaud as lead sponsor.

NCT NCT02555748
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02555748 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Therapeutic Drug Monitoring of Sunitinib and Pazopanib in Advanced or Metastatic Renal Cell Carcinoma
Lead sponsor
Institut Claudius Regaud
Phase
Phase 4
Overall status
Completed
Start date
November 17, 2015
Completion date
January 16, 2020
Enrollment
47 (actual)
Sites
8

Conditions

As the registry lists them; a condition with its own page is linked.

metastatic renal cell cancer